hERG channel agonist NS1643 strongly inhibits invasive astrocytoma cell line SMA-560
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0309438 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Kieran W Benn und 5 weiteren Autor:innen. Beteiligte Einrichtung: Neural Dynamics Laboratory, Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Astrocytoma, Cell Movement, Cell Proliferation, Ether-A-Go-Go Potassium Channels. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Gliomas are highly malignant brain tumours that remain refractory to treatment. Treatment is typically surgical intervention followed by concomitant temozolomide and radiotherapy; however patient prognosis remains poor. Voltage gated ion channels have emerged as novel targets in cancer therapy and inhibition of a potassium selective subtype (hERG, Kv11.1) has demonstrated antitumour activity. Unfortunately blockade of hERG has been limited by cardiotoxicity, however hERG channel agonists have produced similar chemotherapeutic benefit without significant side effects. In this study, electrophysiological recordings suggest the presence of hERG channels in the anaplastic astrocytoma cell line SMA-560, and treatment with the hERG channel agonist NS1643, resulted in a significant reduction in the proliferation of SMA-560 cells. In addition, NS1643 treatment also resulted in a reduction of the secretion of matrix metalloproteinase-9 and SMA-560 cell migration. When combined with temozolomide, an additive impact was observed, suggesting that NS1643 may be a suitable adjuvant to temozolomide and limit the invasiveness of glioma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Neural Dynamics Laboratory, Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
- Department of Surgery, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, Victoria, Australia.
- Department of Neurosurgery, Royal Melbourne Hospital, The University of Melbourne, Victoria, Australia.
- Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, Melbourne, Victoria, Australia.
ORCID-Profile: Kieran W Benn, Christopher R French
Zitieren
APA
Benn, K. W., Yuan, P. H., Chong, H. K., Stylii, S. S., Luwor, R. B., & French, C. R. (2024). hERG channel agonist NS1643 strongly inhibits invasive astrocytoma cell line SMA-560. PLOS ONE. https://doi.org/10.1371/journal.pone.0309438
Vancouver
Benn KW, Yuan PH, Chong HK, Stylii SS, Luwor RB, French CR. hERG channel agonist NS1643 strongly inhibits invasive astrocytoma cell line SMA-560. PLOS ONE. 2024. doi:10.1371/journal.pone.0309438
BibTeX
@article{Benn2024,
author = {Benn, Kieran W and Yuan, Patrick H and Chong, Harvey K and Stylii, Stanley S and Luwor, Rodney B and French, Christopher R},
title = {hERG channel agonist NS1643 strongly inhibits invasive astrocytoma cell line SMA-560},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0309438}
}
EUVIMED